Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cyclophosphamide (cytoxan) (1 trial)
mycophenolate (CellCept) (1 trial)
sargramostim (leukine) (1 trial)
somatropin (protropin) (2 trials)
cladribine (leustatin) (1 trial)
cytarabine (cytosar-u) (1 trial)
Filgrastim (neupogen) (1 trial)
idarubicin (idamycin) (1 trial)
mitoxantrone (novantrone) (1 trial)
sorafenib (nexavar) (1 trial)
cyclosporine (sandimmune) (1 trial)
umbilical cord mesenchymal stem cells (1 trial)
febrifuge (1 trial)
immune globulin (human) (Gamastan) (1 trial)
lactulose (cephulac) (1 trial)
mannitol (Osmitrol) (1 trial)
methylprednisolone (medrol) (1 trial)
paraffin oil (1 trial)
xiyanping (1 trial)
Gonadal Dysgenesis (Phase 2)
Hepatoblastoma (Phase 4)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 4)
Neuroblastoma (Phase 4)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 4)
Retinoblastoma (Phase 4)
Syndrome (Phase 2)
Turner Syndrome (Phase 2)
Trials (8 total)
Trial APIs (19 total)